Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | LAP3 | P28838 | 3/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 3/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2773546 | 0.85 | ALOX15 (0.34) | CTSAACHELAP3 | |
| SCHEMBL6014553 | 0.79 | TSHR (0.55) | METAP1 | |
| SCHEMBL63997 | 0.75 | — | — | |
| SCHEMBL1301793 | 0.73 | — | — | |
| SCHEMBL11005868 | 0.73 | — | — | |
| SCHEMBL5436820 | 0.73 | — | — | |
| SCHEMBL1302819 | 0.73 | — | — | |
| SCHEMBL5423146 | 0.73 | — | — | |
| SCHEMBL5653642 | 0.73 | — | — | |
| SCHEMBL5067272 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-11472898-B2 | Method for surface modification of nanoparticles | CITY UNIVERSITY OF HONG KONG (HK) | 2022-10-18 | — | — | US | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-20110151151-A1 | METHOD OF PRODUCING A PRINT MEDIUM | NALCO COMPANY | 2011-06-23 | — | — | US | claimed |
| EP-1085909-B1 | A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies | ARDENIA INVESTMENTS LTD (GI) | 2005-12-28 | — | — | EP | claimed |
| US-6599507-B2 | Immunostimulation | ARDENIA INVESTMENTS, LTD. (GI) | 2003-07-29 | — | — | US | claimed |
| US-20010034324-A1 | Composition for the treatment of immune deficiencies and methods for its preparation and use | OASMIA PHARMACEUTICAL AB (SE) | 2001-10-25 | — | — | US | claimed |
| EP-1085909-A2 | COMPOSITION FOR THE TREATEMENT OF IMMUNE DEFICIENCIES AND METHODS FOR ITS PREPARATION AND USE | Ardenia Investments Ltd. (GI) | 2001-03-28 | — | — | EP | claimed |
| WO-1999065936-A2 | COMPOSITION FOR THE TREATEMENT OF IMMUNE DEFICIENCIES AND METHODS FOR ITS PREPARATION AND USE | ARDENIA INVESTMENTS LTD. (GI) | 1999-12-23 | — | — | WO | claimed |
| US-5733787-A | COPPER IONS, HYDROPEROXIDE, CHELATING AGENT | BAYER CORPORATION (US) | 1998-03-31 | — | — | US | claimed |
| EP-0814335-A2 | Method for the detection of creatinine | Bayer Corporation (US) | 1997-12-29 | — | — | EP | claimed |
| CN-119113136-A | Application of RNAi agent in treating periodontitis and related diseases | 北京瑞博开拓医药科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119095964-A | Multi-tail and multi-cap mRNA and uses thereof | 博德研究所 | 2024-12-06 | — | — | CN | disclosed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | disclosed |
| US-5733787-A | COPPER IONS, HYDROPEROXIDE, CHELATING AGENT | BAYER CORPORATION (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0537544-A1 | Copper oxidation protein assay | Bayer Corporation (US) | 1993-04-21 | — | — | EP | disclosed |
| EP-0040039-A1 | Ethylene glycol derivatives of ammonioethyl phosphate, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-11-18 | — | — | EP | disclosed |
| US-4213934-A | CORROSION RESISTANCE OF IRON | PETROLITE CORPORATION (US) | 1980-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034324-A1 | Composition for the treatment of immune deficiencies and methods for its preparation and use | ALB, NAPEPLD, TTPA | CTSA 804/4885ACHE 1794/4885LAP3 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.